nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—SLC12A5—forebrain—attention deficit hyperactivity disorder	0.0327	0.0499	CbGeAlD
Bumetanide—SLC12A4—forebrain—attention deficit hyperactivity disorder	0.0271	0.0414	CbGeAlD
Bumetanide—SLC12A4—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.0249	0.0823	CbGpPWpGaD
Bumetanide—SLC12A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.0249	0.0823	CbGpPWpGaD
Bumetanide—SLC12A4—cardiovascular system—attention deficit hyperactivity disorder	0.0229	0.035	CbGeAlD
Bumetanide—SLC12A5—midbrain—attention deficit hyperactivity disorder	0.0216	0.033	CbGeAlD
Bumetanide—SLC12A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.0212	0.07	CbGpPWpGaD
Bumetanide—SLC12A2—forebrain—attention deficit hyperactivity disorder	0.0187	0.0286	CbGeAlD
Bumetanide—SLC12A4—midbrain—attention deficit hyperactivity disorder	0.0179	0.0274	CbGeAlD
Bumetanide—SLC12A5—nervous system—attention deficit hyperactivity disorder	0.0177	0.0271	CbGeAlD
Bumetanide—SLC12A5—central nervous system—attention deficit hyperactivity disorder	0.0171	0.0261	CbGeAlD
Bumetanide—SLC12A5—cerebellum—attention deficit hyperactivity disorder	0.0167	0.0255	CbGeAlD
Bumetanide—Tamsulosin—DRD3—attention deficit hyperactivity disorder	0.0162	0.384	CrCbGaD
Bumetanide—SLC12A2—cardiovascular system—attention deficit hyperactivity disorder	0.0158	0.0242	CbGeAlD
Bumetanide—SLC12A1—forebrain—attention deficit hyperactivity disorder	0.0157	0.024	CbGeAlD
Bumetanide—Tamsulosin—ADRA2A—attention deficit hyperactivity disorder	0.0148	0.35	CrCbGaD
Bumetanide—SLC12A4—nervous system—attention deficit hyperactivity disorder	0.0147	0.0225	CbGeAlD
Bumetanide—SLC12A4—central nervous system—attention deficit hyperactivity disorder	0.0142	0.0217	CbGeAlD
Bumetanide—SLC12A4—cerebellum—attention deficit hyperactivity disorder	0.0139	0.0212	CbGeAlD
Bumetanide—CA7—midbrain—attention deficit hyperactivity disorder	0.0139	0.0212	CbGeAlD
Bumetanide—CA12—forebrain—attention deficit hyperactivity disorder	0.0136	0.0208	CbGeAlD
Bumetanide—SLC12A5—brain—attention deficit hyperactivity disorder	0.0136	0.0207	CbGeAlD
Bumetanide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.0126	0.0416	CbGpPWpGaD
Bumetanide—SLC12A2—midbrain—attention deficit hyperactivity disorder	0.0124	0.0189	CbGeAlD
Bumetanide—CA14—midbrain—attention deficit hyperactivity disorder	0.0115	0.0176	CbGeAlD
Bumetanide—SLC12A4—brain—attention deficit hyperactivity disorder	0.0113	0.0172	CbGeAlD
Bumetanide—Tamsulosin—DRD2—attention deficit hyperactivity disorder	0.0112	0.266	CrCbGaD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0111	0.0368	CbGpPWpGaD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0111	0.0368	CbGpPWpGaD
Bumetanide—CA7—cerebellum—attention deficit hyperactivity disorder	0.0107	0.0164	CbGeAlD
Bumetanide—CA5B—cardiovascular system—attention deficit hyperactivity disorder	0.0103	0.0158	CbGeAlD
Bumetanide—SLC12A2—nervous system—attention deficit hyperactivity disorder	0.0102	0.0155	CbGeAlD
Bumetanide—SLC12A2—central nervous system—attention deficit hyperactivity disorder	0.00979	0.0149	CbGeAlD
Bumetanide—SLC10A1—nervous system—attention deficit hyperactivity disorder	0.0096	0.0147	CbGeAlD
Bumetanide—SLC12A2—cerebellum—attention deficit hyperactivity disorder	0.00957	0.0146	CbGeAlD
Bumetanide—SLCO1A2—forebrain—attention deficit hyperactivity disorder	0.00955	0.0146	CbGeAlD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00947	0.0313	CbGpPWpGaD
Bumetanide—CA9—cerebellum—attention deficit hyperactivity disorder	0.00942	0.0144	CbGeAlD
Bumetanide—SLC10A1—central nervous system—attention deficit hyperactivity disorder	0.00925	0.0141	CbGeAlD
Bumetanide—CA14—cerebellum—attention deficit hyperactivity disorder	0.00893	0.0136	CbGeAlD
Bumetanide—CFTR—brain—attention deficit hyperactivity disorder	0.00885	0.0135	CbGeAlD
Bumetanide—CA7—brain—attention deficit hyperactivity disorder	0.00871	0.0133	CbGeAlD
Bumetanide—SLC12A1—nervous system—attention deficit hyperactivity disorder	0.00852	0.013	CbGeAlD
Bumetanide—CA4—forebrain—attention deficit hyperactivity disorder	0.00844	0.0129	CbGeAlD
Bumetanide—SLC12A1—central nervous system—attention deficit hyperactivity disorder	0.00821	0.0125	CbGeAlD
Bumetanide—SLC12A2—brain—attention deficit hyperactivity disorder	0.00777	0.0119	CbGeAlD
Bumetanide—SLC22A7—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.00764	0.0252	CbGpPWpGaD
Bumetanide—CA12—nervous system—attention deficit hyperactivity disorder	0.0074	0.0113	CbGeAlD
Bumetanide—SLC10A1—brain—attention deficit hyperactivity disorder	0.00734	0.0112	CbGeAlD
Bumetanide—CA14—brain—attention deficit hyperactivity disorder	0.00726	0.0111	CbGeAlD
Bumetanide—CA4—cardiovascular system—attention deficit hyperactivity disorder	0.00714	0.0109	CbGeAlD
Bumetanide—CA12—central nervous system—attention deficit hyperactivity disorder	0.00713	0.0109	CbGeAlD
Bumetanide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—attention deficit hyperactivity disorder	0.00667	0.022	CbGpPWpGaD
Bumetanide—CA5B—nervous system—attention deficit hyperactivity disorder	0.00664	0.0101	CbGeAlD
Bumetanide—SLC22A7—brain—attention deficit hyperactivity disorder	0.00654	0.00999	CbGeAlD
Bumetanide—SLC12A1—brain—attention deficit hyperactivity disorder	0.00651	0.00995	CbGeAlD
Bumetanide—CA5B—central nervous system—attention deficit hyperactivity disorder	0.00639	0.00977	CbGeAlD
Bumetanide—SLC22A6—brain—attention deficit hyperactivity disorder	0.00632	0.00965	CbGeAlD
Bumetanide—SLCO1A2—midbrain—attention deficit hyperactivity disorder	0.0063	0.00963	CbGeAlD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00566	0.0187	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00566	0.0187	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00566	0.0187	CbGpPWpGaD
Bumetanide—CA12—brain—attention deficit hyperactivity disorder	0.00566	0.00864	CbGeAlD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00563	0.0186	CbGpPWpGaD
Bumetanide—CA4—midbrain—attention deficit hyperactivity disorder	0.00558	0.00852	CbGeAlD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0054	0.0178	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0054	0.0178	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0054	0.0178	CbGpPWpGaD
Bumetanide—SLCO1A2—nervous system—attention deficit hyperactivity disorder	0.00518	0.00791	CbGeAlD
Bumetanide—PTGS2—forebrain—attention deficit hyperactivity disorder	0.00517	0.0079	CbGeAlD
Bumetanide—CA5B—brain—attention deficit hyperactivity disorder	0.00508	0.00775	CbGeAlD
Bumetanide—SLCO1A2—central nervous system—attention deficit hyperactivity disorder	0.00499	0.00762	CbGeAlD
Bumetanide—SLC22A8—nervous system—attention deficit hyperactivity disorder	0.00495	0.00756	CbGeAlD
Bumetanide—SLCO1A2—cerebellum—attention deficit hyperactivity disorder	0.00488	0.00745	CbGeAlD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00481	0.0159	CbGpPWpGaD
Bumetanide—SLC22A8—central nervous system—attention deficit hyperactivity disorder	0.00476	0.00728	CbGeAlD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00459	0.0152	CbGpPWpGaD
Bumetanide—CA4—nervous system—attention deficit hyperactivity disorder	0.00458	0.007	CbGeAlD
Bumetanide—CA4—central nervous system—attention deficit hyperactivity disorder	0.00441	0.00674	CbGeAlD
Bumetanide—PTGS2—cardiovascular system—attention deficit hyperactivity disorder	0.00437	0.00668	CbGeAlD
Bumetanide—CA4—cerebellum—attention deficit hyperactivity disorder	0.00431	0.00659	CbGeAlD
Bumetanide—SLCO1A2—brain—attention deficit hyperactivity disorder	0.00396	0.00605	CbGeAlD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00388	0.0128	CbGpPWpGaD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00388	0.0128	CbGpPWpGaD
Bumetanide—SLC22A8—brain—attention deficit hyperactivity disorder	0.00378	0.00578	CbGeAlD
Bumetanide—CA4—brain—attention deficit hyperactivity disorder	0.0035	0.00535	CbGeAlD
Bumetanide—PTGS2—midbrain—attention deficit hyperactivity disorder	0.00341	0.00521	CbGeAlD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00336	0.0111	CbGpPWpGaD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.0033	0.0109	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00305	0.0101	CbGpPWpGaD
Bumetanide—CA9—Cellular response to hypoxia—EP300—attention deficit hyperactivity disorder	0.00295	0.00972	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00286	0.00945	CbGpPWpGaD
Bumetanide—PTGS2—nervous system—attention deficit hyperactivity disorder	0.00281	0.00429	CbGeAlD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00273	0.00901	CbGpPWpGaD
Bumetanide—PTGS2—central nervous system—attention deficit hyperactivity disorder	0.0027	0.00413	CbGeAlD
Bumetanide—PTGS2—cerebellum—attention deficit hyperactivity disorder	0.00264	0.00403	CbGeAlD
Bumetanide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00257	0.0085	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00256	0.00846	CbGpPWpGaD
Bumetanide—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00234	0.00771	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00228	0.00751	CbGpPWpGaD
Bumetanide—PTGS2—brain—attention deficit hyperactivity disorder	0.00215	0.00328	CbGeAlD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00214	0.00706	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00197	0.0065	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00197	0.0065	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00197	0.0065	CbGpPWpGaD
Bumetanide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00196	0.00648	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00196	0.00647	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—RTN4—attention deficit hyperactivity disorder	0.00176	0.0058	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00171	0.00564	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00168	0.00553	CbGpPWpGaD
Bumetanide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00164	0.00541	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00163	0.00538	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00155	0.00512	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00148	0.00488	CbGpPWpGaD
Bumetanide—CA9—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00136	0.00447	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0013	0.0043	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00124	0.0041	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00117	0.00386	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00116	0.00382	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00111	0.00365	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0011	0.00364	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00109	0.00359	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00108	0.00356	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00106	0.0035	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00104	0.00342	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00101	0.00332	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00101	0.00332	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000996	0.00329	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000932	0.00308	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000892	0.00294	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000792	0.00261	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000779	0.00257	CbGpPWpGaD
Bumetanide—CA14—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000763	0.00252	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000763	0.00252	CbGpPWpGaD
Bumetanide—CA14—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000751	0.00248	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000745	0.00246	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000744	0.00245	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000744	0.00245	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000743	0.00245	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.000733	0.00242	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000732	0.00241	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000698	0.0023	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000697	0.0023	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000694	0.00229	CbGpPWpGaD
Bumetanide—CA7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000694	0.00229	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000694	0.00229	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000694	0.00229	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000683	0.00225	CbGpPWpGaD
Bumetanide—CA7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000683	0.00225	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00068	0.00225	CbGpPWpGaD
Bumetanide—CA12—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000643	0.00212	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000643	0.00212	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000635	0.0021	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000635	0.0021	CbGpPWpGaD
Bumetanide—CA12—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000633	0.00209	CbGpPWpGaD
Bumetanide—CA14—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00061	0.00201	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000601	0.00198	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000595	0.00196	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000594	0.00196	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000588	0.00194	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000581	0.00192	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000566	0.00187	CbGpPWpGaD
Bumetanide—CA7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000555	0.00183	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000555	0.00183	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000539	0.00178	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000538	0.00177	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000538	0.00177	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000529	0.00175	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000528	0.00174	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000528	0.00174	CbGpPWpGaD
Bumetanide—CA12—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000514	0.0017	CbGpPWpGaD
Bumetanide—CA4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000513	0.00169	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000513	0.00169	CbGpPWpGaD
Bumetanide—CA4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000505	0.00167	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000499	0.00165	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000492	0.00162	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00049	0.00162	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000469	0.00155	CbGpPWpGaD
Bumetanide—CA14—Metabolism—COMT—attention deficit hyperactivity disorder	0.000462	0.00153	CbGpPWpGaD
Bumetanide—CA14—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000459	0.00152	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000453	0.0015	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—COMT—attention deficit hyperactivity disorder	0.000451	0.00149	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000447	0.00148	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000447	0.00148	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.000431	0.00142	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00043	0.00142	CbGpPWpGaD
Bumetanide—CA7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000421	0.00139	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—COMT—attention deficit hyperactivity disorder	0.000421	0.00139	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000418	0.00138	CbGpPWpGaD
Bumetanide—CA7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000418	0.00138	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000415	0.00137	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000415	0.00137	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00041	0.00135	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000409	0.00135	CbGpPWpGaD
Bumetanide—CA9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000408	0.00135	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000403	0.00133	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00039	0.00129	CbGpPWpGaD
Bumetanide—CA12—Metabolism—COMT—attention deficit hyperactivity disorder	0.00039	0.00129	CbGpPWpGaD
Bumetanide—CA12—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000387	0.00128	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000383	0.00127	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000379	0.00125	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000378	0.00125	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000331	0.00109	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000326	0.00108	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000324	0.00107	CbGpPWpGaD
Bumetanide—PTGS2—Disease—STUB1—attention deficit hyperactivity disorder	0.000322	0.00106	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000315	0.00104	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000314	0.00104	CbGpPWpGaD
Bumetanide—CA4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000311	0.00103	CbGpPWpGaD
Bumetanide—CA4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000309	0.00102	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000265	0.000873	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000265	0.000873	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00026	0.000859	CbGpPWpGaD
Bumetanide—CA9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000251	0.000829	CbGpPWpGaD
Bumetanide—CA9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000249	0.000823	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000242	0.000799	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000232	0.000764	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000223	0.000737	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000212	0.000698	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000201	0.000665	CbGpPWpGaD
Bumetanide—CA14—Metabolism—EP300—attention deficit hyperactivity disorder	0.000198	0.000654	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—EP300—attention deficit hyperactivity disorder	0.000193	0.000638	CbGpPWpGaD
Bumetanide—CA7—Metabolism—EP300—attention deficit hyperactivity disorder	0.00018	0.000595	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—EP300—attention deficit hyperactivity disorder	0.00018	0.000595	CbGpPWpGaD
Bumetanide—CA12—Metabolism—EP300—attention deficit hyperactivity disorder	0.000167	0.000552	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.00016	0.000529	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00016	0.000527	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00016	0.000527	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000159	0.000525	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000157	0.000519	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000154	0.000509	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000153	0.000503	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000146	0.000482	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.00014	0.000461	CbGpPWpGaD
Bumetanide—CA4—Metabolism—EP300—attention deficit hyperactivity disorder	0.000133	0.00044	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000128	0.000422	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000122	0.000401	CbGpPWpGaD
Bumetanide—CA9—Metabolism—EP300—attention deficit hyperactivity disorder	0.000108	0.000355	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—COMT—attention deficit hyperactivity disorder	9.68e-05	0.000319	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.61e-05	0.000317	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.32e-05	0.000308	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—EP300—attention deficit hyperactivity disorder	6.87e-05	0.000227	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EP300—attention deficit hyperactivity disorder	4.96e-05	0.000164	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—EP300—attention deficit hyperactivity disorder	4.15e-05	0.000137	CbGpPWpGaD
